ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Cosmo Pharmaceuticals Nv

Cosmo Pharmaceuticals Nv (0RGI)

126.90
0.00
(0.00%)
Closed January 21 10:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
126.90
Bid
0.00
Ask
0.00
Volume
1
0.00 Day's Range 0.00
126.90 52 Week Range 126.90
Market Cap
Previous Close
126.90
Open
-
Last Trade
1
@
64.8
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
449
Shares Outstanding
17,543,000
Dividend Yield
-
PE Ratio
-451.44
Earnings Per Share (EPS)
-0.28
Revenue
94.23M
Net Profit
-4.93M

About Cosmo Pharmaceuticals Nv

Sector
Pharmaceutical Preparations
Industry
Medicinal Chems,botanicl Pds
Headquarters
Dublin, Irl
Founded
1997
Cosmo Pharmaceuticals Nv is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0RGI. The last closing price for Cosmo Pharmaceuticals Nv was CHF126.90. Over the last year, Cosmo Pharmaceuticals Nv shares have traded in a share price range of CHF 126.90 to CHF 126.90.

Cosmo Pharmaceuticals Nv currently has 17,543,000 shares outstanding. The market capitalization of Cosmo Pharmaceuticals Nv is CHF2.23 billion. Cosmo Pharmaceuticals Nv has a price to earnings ratio (PE ratio) of -451.44.

0RGI Latest News

Invitation to Cosmo's GI Genius™ Q&A session for investors, analysts and journalist

Invitation to Cosmo's GI Genius™ Q&A session for investors, analysts and journalist PR Newswire DUBLIN, April 28, 2021 DUBLIN, April 28, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX:...

Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device f...

Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy PR Newswire DUBLIN, April 12...

Cosmo Full-Year Report 2020: Cosmo returns to operating profit

Cosmo Full-Year Report 2020: Cosmo returns to operating profit PR Newswire DUBLIN, March 26, 2021 DUBLIN, March 26, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) reports Full-Year...

Invitation to Cosmo's 2020 results / 2021 outlook presentation conference call on 26 March 2021

Invitation to Cosmo's 2020 results / 2021 outlook presentation conference call on 26 March 2021 PR Newswire DUBLIN, March 19, 2021 DUBLIN, March 19, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals NV...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100126.9126.9126.9179126.9DE
400126.9126.9126.9334126.9DE
1200126.9126.9126.9449126.9DE
2600126.9126.9126.9541126.9DE
5200126.9126.9126.9819126.9DE
15600126.9126.9126.91114126.9DE
26000126.9126.9126.9921126.9DE

0RGI - Frequently Asked Questions (FAQ)

What is the current Cosmo Pharmaceuticals Nv share price?
The current share price of Cosmo Pharmaceuticals Nv is CHF 126.90
How many Cosmo Pharmaceuticals Nv shares are in issue?
Cosmo Pharmaceuticals Nv has 17,543,000 shares in issue
What is the market cap of Cosmo Pharmaceuticals Nv?
The market capitalisation of Cosmo Pharmaceuticals Nv is CHF 2.23B
What is the 1 year trading range for Cosmo Pharmaceuticals Nv share price?
Cosmo Pharmaceuticals Nv has traded in the range of CHF 126.90 to CHF 126.90 during the past year
What is the PE ratio of Cosmo Pharmaceuticals Nv?
The price to earnings ratio of Cosmo Pharmaceuticals Nv is -451.44
What is the cash to sales ratio of Cosmo Pharmaceuticals Nv?
The cash to sales ratio of Cosmo Pharmaceuticals Nv is 23.62
What is the reporting currency for Cosmo Pharmaceuticals Nv?
Cosmo Pharmaceuticals Nv reports financial results in EUR
What is the latest annual turnover for Cosmo Pharmaceuticals Nv?
The latest annual turnover of Cosmo Pharmaceuticals Nv is EUR 94.23M
What is the latest annual profit for Cosmo Pharmaceuticals Nv?
The latest annual profit of Cosmo Pharmaceuticals Nv is EUR -4.93M
What is the registered address of Cosmo Pharmaceuticals Nv?
The registered address for Cosmo Pharmaceuticals Nv is RIVERSIDE II, SIR JOHN ROGERSON’S QUAY, DUBLIN, 20020
What is the Cosmo Pharmaceuticals Nv website address?
The website address for Cosmo Pharmaceuticals Nv is www.cosmopharmaceuticals.com
Which industry sector does Cosmo Pharmaceuticals Nv operate in?
Cosmo Pharmaceuticals Nv operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NTOGNostra Terra Oil And Gas Company Plc
0.043p
(36.51%)
524.2M
BSFABsf Enterprise Plc
3.375p
(35.00%)
13.75M
STBSecure Trust Bank Plc
465.00p
(33.62%)
929.55k
TIATialis Essential It Plc
26.50p
(23.26%)
105.62k
CBGClose Brothers Group Plc
298.40p
(21.90%)
4.6M
NTQEnteq Technologies Plc
1.25p
(-23.31%)
3.22M
BANKFiinu Plc
8.625p
(-15.85%)
20.47M
TIRTiger Royalties And Investments Plc
0.135p
(-15.63%)
75.44M
RCGHRc365 Holding Plc
1.80p
(-14.29%)
1.7M
INDIIndus Gas Limited
7.80p
(-13.33%)
214.66k
NTVONativo Resources Plc
0.0021p
(0.00%)
2.71B
PREMPremier African Minerals Limited
0.026p
(-3.70%)
623.1M
NTOGNostra Terra Oil And Gas Company Plc
0.043p
(36.51%)
524.2M
TRPTower Resources Plc
0.0305p
(0.00%)
504.66M
SYMESupply@me Capital Plc
0.003p
(-3.23%)
469.16M

Discussion

View Full Feed
RickNagra RickNagra 40 seconds ago
Fannie responses towards the end.

https://www.finance.senate.gov/imo/media/doc/responses_to_questions_for_the_record_to_scott_bessent.pdf

FNMA
LTListener LTListener 48 seconds ago
This thought has been on the back of my mind as well..

You mentioned it kinda felt they were waiting on a few more items... Maybe capital is lined up and just waiting for them to kick off the phase 2 SCI and/or the phase 1/2 dronabinol trials that the VA/UIC are collaborating on...
RSPI
vlispxpert vlispxpert 51 seconds ago
LITM ooooh yeah...I been saying dollars, looks like that's coming soon imo
LITM
bluebird50 bluebird50 1 minute ago
Nah, sorry Charlie! 
ILLR
Prinz18 Prinz18 1 minute ago
Domain nationalshrimp.com for sale!?
SHMP
linkvest linkvest 1 minute ago
Companies leadership----- https://telvantis.com/investors/leadership/
RDAR
rosemountbomber rosemountbomber 2 minutes ago
Actually, the study we have been discussing here catalogued or measured patients on IPE vs those on O-3. Although most would be on Medicare or have Vascepa covered, it could very well be that some in the study were on GV.

https://www.jacc.org/doi/10.1016/S0735-1097%2824%2903313-8
AMRN
train train 2 minutes ago
With Trump in, there will be more concentration of resources here in the US and Canada.

Charlie
AKEMF
konshe konshe 2 minutes ago
CEO, time to get India news out this week
RDGL
Meowza Meowza 2 minutes ago
https://media.tenor.com/o6DdzVC5puwAAAAe/witches.png
AMRN
boston745 boston745 2 minutes ago
This is consistent with my analysis. 12 PT is consistent with the downtrend continuing but fills the gap. Higher is needed to breakout of current trend. A big new contract will send this well over 12 and should help Lind exercise its Series F warrants before August. Despite whats being claimed on ST
SINT
vlispxpert vlispxpert 2 minutes ago
If I could start .32 & get flash dip .28's....I'd be interested...good luck!
KISSINGER KISSINGER 2 minutes ago
SHORT SQUEEZE YOUR A$$ KNUCKLEHEAD....!!!! You can only get a short squeeze out of a SCAM once. This is a SCAM and your squuze lasted all of an HOUR last time...LOL
https://investorshub.advfn.com/uimage/uploads/2025/1/21/kctxiBokjLryIQAAGmTT.jpg
ZENA
RIGATONI RIGATONI 2 minutes ago
$6.25 ~Rig
PonderosaPack PonderosaPack 2 minutes ago
50 Burger Bro.
IONQ
linkvest linkvest 3 minutes ago
Telvantis Inc. news leases----- https://telvantis.com/press-releases/
RDAR
dexprs dexprs 3 minutes ago
LLY has a strong support around 712. I include that number in my formula for selling Calls in LLY.
LLY
JKS3 JKS3 3 minutes ago
Those guys have been right on SAVA's data.
AVXL
Clayton Bigsbee Clayton Bigsbee 3 minutes ago
They are not satisfying the "1 year rule" currently. The merger hasn't been signed off as official, Hahalolo has bought control of shell company FBEC. You'll see combined financials of shell company and Hahalolo when the merger is official. Once current and on OTCQB or OTCQX the 1 year requirement f
FBEC
CHARLIESAN CHARLIESAN 3 minutes ago
A new dawn in America. Disposable income will be up as Trump brings back the economy thru business like decisions. Spending will be cut; oil will flow; energy down lowering inflation. Bite the apple now!!
My last shot at a bite; hope I can make it a good one.
BYD
stockprofitter stockprofitter 3 minutes ago
Does Mark have to report his holding$$$..!?

https://x.com/markcalabria/status/1881739921901408611?s=61&t=KEFTLxsG2C318JcOnlHS4Q
FNMA
shell3 shell3 3 minutes ago
Schwab as was Scottrade then TDAmeritrade now Schwab - Platforms vs Broker - Trading stocks that see-no-bottom the Platform’s make you want the Trade and have to call a Broker when the Platform won’t allow — But have always been able to pay for the Trade and this Broker because all done - Maybe why
MEDH
Sammy boy Sammy boy 4 minutes ago
VSAT insider Wasserman Schultz stock exploding, I told ya!
VSAT
TurboHaven10 TurboHaven10 4 minutes ago
My broker is showing me 10,000 lots of bids and asks?
AZRH
linkvest linkvest 4 minutes ago
Just a reminder of some news we are looking forward to hearing more about ---- https://www.globenewswire.com/news-release/2024/12/18/2999008/0/en/Raadr-Doing-Business-as-Telvantis-Announces-45-Million-Working-Capital-Facility-to-Drive-Accelerated-Growth.html
RDAR